When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CMVLF - ObsEva Phase 3 Data And Other News: The Good Bad And Ugly Of Biopharma
Cellectis Romainville Ord
ObsEva Reports Positive Data from Phase 3 Uterine Fibroids Studies
ObsEva SA (OBSV) announced positive top line data from its PRIMROSE 1 and 2 studies. PRIMROSE 1 met its primary endpoint at week 24 while PRIMROSE 2 data showed that continued treatment with linzagolix for 52 weeks offers sustained efficacy and is well tolerated. The company is now looking to prepare its regulatory submissions.
PRIMROSE 1 and 2 study aimed to evaluate the efficacy and safety of Yselty® (linzagolix) in women with heavy menstrual bleeding due to uterine fibroids. The data from the